MAPT and Alzheimer disease: Such experimental evidence supports the data-driven (biomarker-based) hypothetical model of AD clinical-biological continuum whereby brain accumulation of Aβ may either facilitate being permissive to spreading of tau pathology that is tightly associated with the clinical evolution of the disease [22].